#Retatrutide To view or add a comment, sign in Major FDA Milestone in Obesity Treatment The FDA has approved the first oral GLP-1 receptor agonistan oral semaglutide pillfor chronic weight management, providing a convenient non-injectable alternative to previous therapies
General information about NYRx, the Medicaid Pharmacy Program can be found HERE, along with member information
Watson K, Nasca C, Aasly L, McEwen B, Rasgon N (2018) Insulin resistance, an unmasked culprit in depressive disorders: promises for interventions
If you have a reaction where it looks like you might get S N 2 or E2, look closely first is there any chance of a simple acid-base reaction
Contraindications aren't absolute
However, a study on different doses showed that patients taking 3 mg of liraglutide (the highest Saxenda dose) lost an average of 6.0% body fat